| AxoGen, Inc. (AXGN.OB), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it will release its financial results for the period ended March 31, 2012, after the close of U.S. financial markets on May 14, 2012. An accompanying conference call hosted by Karen Zaderej, Chief Executive Officer, and Greg Freitag, Chief Financial Officer, to discuss results will be held at...continued AXGN |
Friday, May 4, 2012
AxoGen, Inc. Announces Release Date of 2012 First Quarter Results and Conference Call
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment